Cargando…

No Evidence for FANCF Gene Silencing in Head-and-Neck Squamous Cell Carcinomas

Detalles Bibliográficos
Autores principales:	Ameziane, Najim, Chen, Fei, Leemans, C. René, Brakenhoff, Ruud H., Joenje, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2009
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618916/ https://www.ncbi.nlm.nih.gov/pubmed/19096150 http://dx.doi.org/10.3233/CLO-2009-0462

Ejemplares similares

Resection Margins in Head and Neck Cancer Surgery: An Update of Residual Disease and Field Cancerization
por: Pierik, Annouk S., et al.
Publicado: (2021)

At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell Carcinoma
por: Wondergem, Niels E., et al.
Publicado: (2021)

The First Case of Acute Myeloid Leukemia With Underlying Fanconi Anemia due to FANCF Variants in Korea
por: Suh, Eunsang, et al.
Publicado: (2023)

The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites
por: Wondergem, Niels E., et al.
Publicado: (2020)

Ovarian cancer‐derived copy number alterations signatures are prognostic in chemoradiotherapy‐treated head and neck squamous cell carcinoma
por: Essers, Paul B.M., et al.
Publicado: (2020)

Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures
por: Mes, Steven W., et al.
Publicado: (2020)

Immunogenomic alterations of head and neck squamous cell carcinomas stratified by smoking status
por: Huang, Yixuan, et al.
Publicado: (2021)

Rabbit VX2 head and neck squamous cell models for translational head and neck theranostic technology development
por: Muhanna, Nidal, et al.
Publicado: (2021)

Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck
por: Wilting, Saskia M, et al.
Publicado: (2009)

Potentially novel options for treatment of HPV-attributable head and neck cancer
por: Brakenhoff, Ruud H.
Publicado: (2013)

Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer
por: Lim, S L, et al.
Publicado: (2008)

Radiochemotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer
por: Schäfer, C, et al.
Publicado: (2006)

Tumor microenvironment characterization in head and neck squamous carcinoma reveals distinct genomic alterations and clinical outcomes
por: Shi, Run, et al.
Publicado: (2020)

The Prognostic Value of TP53 Alteration in Patients with Head and Neck Squamous Cell Carcinoma Receiving Immunotherapy
por: Jiang, Chao, et al.
Publicado: (2022)

Molecular Detection of Minimal Residual Cancer in Surgical Margins of Head and Neck Cancer Patients
por: Graveland, A. Peggy, et al.
Publicado: (2009)

BIRC2–BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia
por: Roohollahi, Khashayar, et al.
Publicado: (2022)

Matrisomal genes in squamous cell carcinoma of head and neck influence tumor cell motility and response to cetuximab treatment
por: Goh, Kah Yee, et al.
Publicado: (2022)

Publisher Correction: BIRC2–BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia
por: Roohollahi, Khashayar, et al.
Publicado: (2022)

Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors
por: de Ruiter, Emma J., et al.
Publicado: (2020)

Diagnosis of Fanconi Anemia: Mutation Analysis by Multiplex Ligation-Dependent Probe Amplification and PCR-Based Sanger Sequencing
por: Gille, Johan J. P., et al.
Publicado: (2012)

Gene Silencing of FANCF Potentiates the Sensitivity to Mitoxantrone through Activation of JNK and p38 Signal Pathways in Breast Cancer Cells
por: Li, Yanlin, et al.
Publicado: (2012)

DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells
por: Martens-de Kemp, Sanne R., et al.
Publicado: (2013)

In Reply: TP53 Alteration Status and Tumor Mutational Burden Score: Prevalence and Prognosis in Head and Neck Squamous Cell Carcinoma
por: Burcher, Kimberly M, et al.
Publicado: (2022)

Current evidence on confocal laser endomicroscopy for noninvasive head and neck cancer imaging
por: Yang, Xi, et al.
Publicado: (2020)

The FANCC–FANCE–FANCF complex is evolutionarily conserved and regulates meiotic recombination
por: Singh, Dipesh Kumar, et al.
Publicado: (2023)

A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma
por: Hussein, Aisha A., et al.
Publicado: (2018)

Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications
por: van Harten, Anne M., et al.
Publicado: (2021)

Lower platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma: a retrospective analysis
por: Furlan, Carlo, et al.
Publicado: (2015)

Salvage surgery in head and neck cancer
por: van Weert, Stijn, et al.
Publicado: (2020)

A Prospectively Validated Prognostic Model for Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck Based on Radiomics of Computed Tomography Images
por: Keek, Simon A., et al.
Publicado: (2021)

Disproportional enrichment of FoxP3(+)CD4(+) regulatory T cells shapes a suppressive tumour microenvironment in head and neck squamous cell carcinoma
por: Park, Seyeon, et al.
Publicado: (2022)

Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition
por: van Harten, Anne M., et al.
Publicado: (2020)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck
por: de Boer, D. Vicky, et al.
Publicado: (2017)

A Protein Prioritization Approach Tailored for the FA/BRCA Pathway
por: Haitjema, Anneke, et al.
Publicado: (2013)

Correction: A Protein Prioritization Approach Tailored for the FA/BRCA Pathway
por: Haitjema, Anneke, et al.
Publicado: (2013)

DNA methylation-mediated Klotho silencing is an independent prognostic biomarker of head and neck squamous carcinoma
por: Zhu, Yun, et al.
Publicado: (2019)

Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells
por: Klaassen, I, et al.
Publicado: (2001)

Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy
por: Keek, Simon, et al.
Publicado: (2020)

NECESSITY OF PSYCHOLOGICAL ASSESSMENT IN THE HEAD AND NECK CANCER
por: Mishra, Anupam
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_3n1d682q8qmh7jvhg1fvfvpuai